COMMON TRANSCRIPTIONAL PROGRAMS AND THE ROLE OF CHEMOKINE (C-C MOTIF) LIGAND 20 (CCL20) IN CELL MIGRATION OF CHOLANGIOCARCINOMA

被引:3
|
作者
Maung, Hay Mar Win [1 ]
Chan-On, Waraporn [2 ]
Kunkeaw, Nawapol [3 ]
Khaenam, Prasong [1 ]
机构
[1] Mahidol Univ, Fac Med Technol, Ctr Standardizat & Prod Validat, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
[2] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
[3] Mahidol Univ, Inst Mol Biosci, Phutthamonthon Dist 73170, Nakhon Pathom, Thailand
来源
EXCLI JOURNAL | 2020年 / 19卷
关键词
CCL20; CCR6; cholangiocarcinoma (CCA); microarray; epithelial-mesenchymal transition (EMT); cell migration; EPITHELIAL-MESENCHYMAL TRANSITION; EXPRESSION; CANCER; CCR6; PROLIFERATION;
D O I
10.17179/excli2019-1893
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The incidence of cholangiocarcinoma (CCA) has risen in many countries, but there is still no appropriate screening and treatment available. The growing number of microarray data published todays can be a powerful resource for the discovery of biomarkers to tackle challenges in the management of CCA. This study analyzed multiple microarray datasets to identify the common transcriptional networks in CCA and select a possible biomarker for functional study in CCA cell lines. A systematic searching identified 4 microarray datasets from Gene Expression Omnibus (GEO) repository and PubMed articles.Differential expression analysis between tumor and normal tissues was performed in each dataset. In order to characterize the common expression pattern, differentially expressed genes (DEGs) from all datasets were combined and visualized by hierarchical clustering and heatmap. Gene enrichment analysis performed in each cluster revealed that over-expressed DEGs were enriched in cell cycle, cell migration and response to cytokines while under-expressed DEGs were enriched in metabolic processes such as oxidation-reduction, lipid, and drug. To explain tumor characteristics, genes enriched in cell migration and response to cytokines were further investigated. Among these genes, CCL20 was selected for functional study because its role has never been studied in CCA. Moreover, its signaling may be regulated by disrupting its only receptor, CCR6. Treatment with recombinant CCL20 induced higher cell migration and increased expression of N-cad. In contrast, knockdown of CCR6 by siRNA reduced cell migration ability and decreased N-cadherin level. Altogether, these results suggested the contribution of CCL20/CCR6 signaling in cell migration through epithelialmesenchymal transition process. Thus, CCL20/CCR6 signaling might be a target for the management of CCA.
引用
收藏
页码:154 / 166
页数:13
相关论文
共 50 条
  • [41] Role of chemokine C-C motif ligand-1 in acute and chronic pulmonary inflammations
    Kishi, Hiroyuki
    Sato, Masamichi
    Shibata, Yoko
    Sato, Kento
    Inoue, Sumito
    Abe, Shuichi
    Kimura, Tomomi
    Nishiwaki, Michiko
    Yamauchi, Keiko
    Nemoto, Takako
    Igarashi, Akira
    Tokairin, Yoshikane
    Nakajima, Osamu
    Kubota, Isao
    SPRINGERPLUS, 2016, 5
  • [42] Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meeting
    Koyner, Jay L.
    Arndt, Christian
    de Irujo, Jaume Baldira Martinez
    Coelho, Silvia
    Garcia-Montesinos de la Pena, Manuel
    di Girolamo, Luca
    Joannidis, Michael
    Jorge-Monjas, Pablo
    Koch, Christian
    Lobaz, Steven
    Meyer, Alain
    Ostermann, Marlies
    Pertica, Nicoletta
    Prowle, John R.
    Silversides, Jon
    Zarbock, Alexander
    Echeverri, Jorge
    Harenski, Kai
    Forni, Lui G.
    RENAL FAILURE, 2024, 46 (01)
  • [43] Human Papillomavirus Type 8 Interferes with a Novel C/EBPβ-Mediated Mechanism of Keratinocyte CCL20 Chemokine Expression and Langerhans Cell Migration
    Sperling, Tanya
    Oldak, Monika
    Walch-Rueckheim, Barbara
    Wickenhauser, Claudia
    Doorbar, John
    Pfister, Herbert
    Malejczyk, Magdalena
    Majewski, Slawomir
    Keates, Andrew C.
    Smola, Sigrun
    PLOS PATHOGENS, 2012, 8 (07) : 23
  • [44] Chemokine C-C motif ligand 7 as a Costimulatory Signal on Mast Cell Activation and Motility
    Kuo, Chuan-Hui
    Collins, Andrea
    Ohbayashi, Masaharu
    Ono, Santa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [45] Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20
    Lahoti, Tejas S.
    Boyer, Jacob A.
    Kusnadi, Ann
    Muku, Gulsum E.
    Murray, Iain A.
    Perdew, Gary H.
    TOXICOLOGICAL SCIENCES, 2015, 148 (01) : 229 - 240
  • [46] C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
    Wang, Xiangzi
    Niu, Xiaofei
    Wang, Yingkai
    Liu, Yang
    Yang, Cheng
    Chen, Xuyi
    Qi, Zhongquan
    NEURAL REGENERATION RESEARCH, 2025, 20 (08) : 2231 - 2244
  • [47] Chemokine (C-C) motif ligand 20 is regulated by PGF2α-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation
    Wallace, Alison E.
    Catalano, Rob D.
    Anderson, Richard A.
    Jabbour, Henry N.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 331 (01) : 129 - 135
  • [48] C-C Motif Ligand 7 and C-C Motif Chemokine Receptor 3 Dysregulation in Patients With Scrub Typhus and Association With Mortality
    Ueland, Thor
    Astrup, Elisabeth
    Otterdal, Kari
    Lekva, Tove
    Janardhanan, Jeshina
    Michelsen, Annika E.
    Aukrust, Pal
    Varghese, George M.
    Damas, Jan K.
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [49] Role of CC-chemokine receptor 6 (CCR6) and CC-chemokine ligand 20 (CCL20) mediated immunosurveillance in malignant melanoma
    Martin-Garcia, D.
    Enk, A.
    Lonsdorf, A. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S208 - S208
  • [50] Role of CC-chemokine Receptor 6 (CCR6) and CC-chemokine Ligand 20 (CCL20) mediated immunosurveillance in malignant melanoma
    Martin-Garcia, D.
    Enk, A. H.
    Lonsdorf, A. S.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E17 - E18